| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |